127 related articles for article (PubMed ID: 11814809)
1. Synthesis and first biological evaluation of 1-aza-9-oxafluorenes as novel lead structures for the development of small-sized cytostatics.
Brachwitz K; Hilgeroth A
Bioorg Med Chem Lett; 2002 Feb; 12(3):411-3. PubMed ID: 11814809
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the first cytostatically active 1-aza-9-oxafluorenes as novel selective CDK1 inhibitors with P-glycoprotein modulating properties.
Brachwitz K; Voigt B; Meijer L; Lozach O; Schächtele C; Molnár J; Hilgeroth A
J Med Chem; 2003 Feb; 46(5):876-9. PubMed ID: 12593668
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of isoindoloquinoline derivatives as potential antitumor agents.
Lee H; Jeong I; Yang SI
Arch Pharm Res; 2002 Aug; 25(4):416-20. PubMed ID: 12214847
[TBL] [Abstract][Full Text] [Related]
4. Novel imidazo[4,5-b]pyridine and triaza-benzo[c]fluorene derivatives: synthesis, antiproliferative activity and DNA binding studies.
Hranjec M; Lučić B; Ratkaj I; Pavelić SK; Piantanida I; Pavelić K; Karminski-Zamola G
Eur J Med Chem; 2011 Jul; 46(7):2748-58. PubMed ID: 21524829
[TBL] [Abstract][Full Text] [Related]
5. Novel CDK inhibition profiles of structurally varied 1-aza-9-oxafluorenes.
Voigt B; Meijer L; Lozach O; Schächtele C; Totzke F; Hilgeroth A
Bioorg Med Chem Lett; 2005 Feb; 15(3):823-5. PubMed ID: 15664865
[TBL] [Abstract][Full Text] [Related]
6. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antitumor activity, molecular modeling, and DNA binding properties of a new series of imidazonaphthalimides.
Braña MF; Cacho M; García MA; de Pascual-Teresa B; Ramos A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle MF; Yuste M
J Med Chem; 2002 Dec; 45(26):5813-6. PubMed ID: 12477366
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
Chen Z; Cao R; Shi B; Guo L; Sun J; Ma Q; Fan W; Song H
Eur J Med Chem; 2011 Oct; 46(10):5127-37. PubMed ID: 21875764
[TBL] [Abstract][Full Text] [Related]
9. [Cl958].
Lansiaux A; Caty A; Deligny N; Bailly C
Bull Cancer; 2002 Jun; 89(6):575-8. PubMed ID: 12135857
[No Abstract] [Full Text] [Related]
10. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
11. Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; Barone V; Pani A; Tramontano E; La Colla P; Murgioni C; Serra I; Setzu G; Loddo R
J Med Chem; 2002 Nov; 45(24):5205-16. PubMed ID: 12431048
[TBL] [Abstract][Full Text] [Related]
12. Potential antitumor agents. 57. 2-Phenylquinoline-8-carboxamides as "minimal" DNA-intercalating antitumor agents with in vivo solid tumor activity.
Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1989 Feb; 32(2):396-401. PubMed ID: 2913299
[TBL] [Abstract][Full Text] [Related]
13. Highly stable phenanthridinium frameworks as a new class of tunable DNA binding agents with cytotoxic properties.
Parenty AD; Smith LV; Guthrie KM; Long DL; Plumb J; Brown R; Cronin L
J Med Chem; 2005 Jul; 48(14):4504-6. PubMed ID: 15999988
[TBL] [Abstract][Full Text] [Related]
14. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
15. DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma.
Varrica MG; Zagni C; Mineo PG; Floresta G; Monciino G; Pistarà V; Abbadessa A; Nicosia A; Castilho RM; Amata E; Rescifina A
Eur J Med Chem; 2018 Jan; 143():583-590. PubMed ID: 29207341
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs.
Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G
Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents.
Alcaro S; Arena A; Neri S; Ottanà R; Ortuso F; Pavone B; Vigorita MG
Bioorg Med Chem; 2004 Apr; 12(7):1781-91. PubMed ID: 15028268
[TBL] [Abstract][Full Text] [Related]
18. Novel DNA intercalators without basic side chains as efficient antitumor agents: design, synthesis and evaluation of benzo-[c,d]-indol-malononitrile derivatives.
Li X; Wang Q; Qing Y; Lin Y; Zhang Y; Qian X; Cui J
Bioorg Med Chem; 2010 May; 18(9):3279-84. PubMed ID: 20385497
[TBL] [Abstract][Full Text] [Related]
19. Novel thiazonaphthalimides as efficient antitumor and DNA photocleaving agents: effects of intercalation, side chains, and substituent groups.
Li Z; Yang Q; Qian X
Bioorg Med Chem; 2005 Aug; 13(16):4864-70. PubMed ID: 15925513
[TBL] [Abstract][Full Text] [Related]
20. Potential antitumor agents. 55. 6-Phenylphenanthridine-4-carboxamides: a new class of DNA-intercalating antitumor agents.
Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1988 Apr; 31(4):774-9. PubMed ID: 3351855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
